RiceBran Technologies (RIBT) 10-K 17 Mar 22 2021 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 17, 2022	Jun. 30, 2021
Document Information [Line Items]
Entity Central Index Key	0001063537
Entity Registrant Name	RiceBran Technologies
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	001-36245
Entity Incorporation, State or Country Code	CA
Entity Tax Identification Number	87-0673375
Entity Address, Address Line One	25420 Kuykendahl Rd., Suite B300
Entity Address, City or Town	Tomball
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77375
City Area Code	281
Local Phone Number	675-2421
Title of 12(b) Security	Common Stock, no par value per share
Trading Symbol	RIBT
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 38,100,000
Entity Common Stock, Shares Outstanding		51,814,425
Auditor Name	RSM US LLP
Auditor Location	Houston, Texas
Auditor Firm ID	49

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 5,825	$ 5,263
Accounts receivable, net of allowance for doubtful accounts of $18 and $9	4,136	2,819
Inventories	2,444	1,878
Other current assets	810	1,380
Total current assets	13,215	11,340
Property and equipment, net	15,444	16,367
Operating lease right-of-use assets	2,127	2,452
Intangible assets	527	722
Goodwill	0	3,915
Total assets	31,313	34,796
Current liabilities:
Accounts payable	826	955
Commodities payable	1,702	825
Accrued salary, wages and benefits	787	601
Accrued expenses	683	536
Operating lease liabilities, current portion	382	344
Due under insurance premium finance agreements	128	126
Due under factoring agreement	3,379	1,785
Finance lease liabilities, current portion	86	82
Long-term debt, current portion	1,183	572
Total current liabilities	9,156	5,826
Operating lease liabilities, less current portion	1,948	2,330
Finance lease liabilities, less current portion	100	113
Long-term debt, less current portion	1,356	3,107
Derivative warrant liabilty	258	0
Total liabilities	12,818	11,376
Commitments and contingencies
Shareholders' equity:
Preferred stock, 20,000,000 shares authorized: Series G, convertible, 3,000 shares authorized, stated value $150 and $225, 150 and 225 shares, issued and outstanding	75	112
Common stock, no par value, 150,000,000 shares authorized, 51,589,674 shares and 45,238,087 shares, issued and outstanding	326,279	322,218
Accumulated deficit	(307,859)	(298,910)
Total shareholders' equity	18,495	23,420
Total liabilities and shareholders' equity	$ 31,313	$ 34,796

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Accounts receivable, allowance for doubtful accounts	$ 18	$ 9
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	51,589,674	45,238,087
Common stock, shares outstanding (in shares)	51,589,674
Series G Preferred Stock [Member]
Preferred stock, shares authorized (in shares)	3,000	3,000
Preferred stock, stated value (in dollars per share)	$ 150	$ 225
Preferred stock, shares issued (in shares)	150	225
Preferred stock, shares outstanding (in shares)	150	225

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenues	$ 31,131	$ 26,199
Cost of goods sold	30,689	28,670
Gross profit (loss)	442	(2,471)
Selling, general and administrative expenses	7,087	7,971
Impairment of goodwill	3,915	0
Loss on disposition and involuntary conversion of property and equipment	6	847
Operating loss	(10,566)	(11,289)
Other income (expense):
Interest expense	(463)	(318)
Interest income	1	20
Gain on extinguishmenbt of PPP Loan	1,792	0
Change in fair value of derivative warrant liability	389	0
Other income	4	4
Other expense	(85)	(128)
Total other income (expense)	1,638	(422)
Loss before income taxes	(8,928)	(11,711)
Income tax expense	(21)	(19)
Net loss	$ (8,949)	$ (11,730)
Loss per common share:
Basic (in dollars per share)	$ (0.19)	$ (0.29)
Diluted (in dollars per share)	$ (0.19)	$ (0.29)
Weighted average number of shares outstanding:
Basic (in shares)	47,738,948	41,131,782
Diluted (in shares)	47,738,948	41,131,782

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2019	225	40,074,483
Balance at Dec. 31, 2019	$ 112	$ 318,811	$ (287,180)	$ 31,743
Sales of common stock, net of costs (in shares)		4,850,489
Sales of common stock, net of costs	$ 0	$ 2,318	0	2,318
Common stock awards under equity incentive plans (in shares)	0	214,234
Common stock awards under equity incentive plans	$ 0	$ 1,041	0	1,041
Exercise of common stock warrants (in shares)	0	67,577
Exercise of common stock warrants	$ 0	$ 12	0	12
Common stock issued to vendors (in shares)	0	31,304
Common stock issued to vendors	$ 0	$ 36	0	36
Basic and diluted - net loss	$ 0	$ 0	(11,730)	(11,730)
Balance (in shares) at Dec. 31, 2020	225	45,238,087
Balance at Dec. 31, 2020	$ 112	$ 322,218	(298,910)	23,420
Common stock awards under equity incentive plans (in shares)	0	708,584
Common stock awards under equity incentive plans	$ 0	$ 1,114	0	1,114
Exercise of common stock warrants (in shares)	0	2,485,434
Exercise of common stock warrants	$ 0	$ 171	0	171
Common stock issued to vendors (in shares)	0	24,000
Common stock issued to vendors	$ 0	$ 18	0	18
Basic and diluted - net loss	$ 0	$ 0	(8,949)	(8,949)
Sales of common stock and common stock warrants, net of costs (in shares)	0	3,062,395
Sales of common stock and common stock warrants, net of costs	$ 0	$ 2,721	0	2,721
Conversion of preferred stock into common stock (in shares)	(75)	71,174
Conversion of preferred stock into common stock	$ (37)	$ 37	0	0
Balance (in shares) at Dec. 31, 2021	150	51,589,674
Balance at Dec. 31, 2021	$ 75	$ 326,279	$ (307,859)	$ 18,495

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flow from operating activities:
Net loss	$ (8,949)	$ (11,730)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	2,397	2,393
Amortization	195	228
Stock and share-based compensation	1,135	1,077
Impairment of goodwill	3,915	0
Loss on disposition and involuntary conversion of property and equipment	6	847
Gain on extinguishment of PPP loan	(1,792)	0
Change in fair value of derivative warrant liability	(389)	0
Accretion of interest	98	95
Other	(3)	(84)
Changes in operating assets and liabilities:
Accounts receivable	(1,332)	997
Inventories	(566)	(980)
Accounts payable and accrued expenses	280	(709)
Commodities payable	876	(4)
Other	(69)	(76)
Net cash used in operating activities	(4,198)	(7,946)
Cash flows from investing activities:
Purchases of property and equipment	(1,440)	(1,184)
Proceeds from insurance on involuntary conversion	639	250
Proceeds from sale of property and equipment	3	15
Net cash used in investing activities - continuing operations	(798)	(919)
Cash flows from financing activities:
Advances on factoring agreement	31,038	27,450
Payments on factoring agreement	(29,519)	(27,583)
Advances on insurance premium finance agreements	962	743
Payments on insurance premium finance agreements	(960)	(733)
Advances on long-term debt, net of issuance costs	1,167	3,762
Payments of long-term debt and finance lease liabilities	(665)	(285)
Proceeds from issuances of common stock and warrants, net of issuance costs	3,364	2,318
Proceeds from common stock warrant exercises	171	12
Net cash provided by financing activities	5,558	5,684
Net change in cash and cash equivalents	562	(3,181)
Cash and cash equivalents, beginning of period	5,263	8,444
Cash and cash equivalents, end of period	5,825	5,263
Net change in cash and cash equivalents and restricted cash	562	(3,181)
Supplemental disclosures:
Cash paid for interest	354	223
Cash paid for income taxes	$ 18	$ 7

Note 1 - Liquidity and Manageme

Note 1 - Liquidity and Management's Plan	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	NOTE 1. ’ S PLAN Our multi-year history of operating losses and negative operating cash flows from continuing operations raised substantial doubt about our ability to continue as a going concern before consideration of management’s plans, however after consideration of management’s plans and the factors below, we believe substantial doubt about our ability to continue as a going concern within one 1 Significant Cash Reserves December 31, 2021, 2 Declining Operating Losses 2021, ● The transition to positive gross profits in 2021 ● An 11% reduction in selling, general, and administrative expenses in 2021, 2020, 3 Access to Equity Funding second 2021, 4 Ability to Leverage and/or Sell Real-estate Assets three no

Note 2 - Business and Summary o

Note 2 - Business and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	NOTE 2. Business We are a specialty ingredient company focused on the development, production, and marketing of products derived from traditional and ancient small grains. We create and produce products utilizing proprietary processes to deliver improved nutrition, ease of use, and extended shelf-life, while addressing consumer demand for all natural, non-GMO and organic products. We believe our products can become valuable alternatives to traditional food ingredients. Notably, we apply our proprietary technologies to convert raw rice bran into stabilized rice bran (SRB), and high value-added derivative products including: RiBalance, a rice bran nutritional package derived from SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a fiber rich insoluble derivative of RiBalance and ProRyza, a rice bran protein-based product; and a variety of other valuable derivatives extracted from these core products. In granular form, SRB is a food additive used in products for human and animal consumption. We believe SRB has certain qualities that make it more attractive than additives based on the by-products of other agricultural commodities, such as corn, soybeans, wheat, and yeast. Our SRB products and SRB derivatives support the production of healthy, natural, hypoallergenic, gluten free, and non-genetically modified ingredients and supplements for use in meats, baked goods, cereals, coatings, health foods, and high-end animal nutrition. Our target customers are food and animal nutrition manufacturers, wholesalers and retailers, both domestically and internationally. We manufacture and distribute SRB from four two one No. 1 No. 2 one one Segment Reporting An operating segment is defined as a component of a business for which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and evaluate performance. The “Segment Reporting” topic of the Financial Accounting Standard Board (FASB) accounting standards codification requires that public companies report certain information about operating segments. It also requires that public companies report certain information about their products and services, the geographic areas in which they operate, and their major customers. Given the integrated nature of these facilities, we have one one Recent Accounting Guidance Recent accounting standards not The following discusses the accounting standard(s) not In June 2016, ASU No. 2016 13 Financial Instruments Credit Losses (Topic 326 Measurement of Credit Losses on Financial Instruments 2023 January 1, 2023. not Recently adopted accounting standards In August 2020, ASU 2020 06, 470 20 Contracts in Entity s Own Equity (Subtopic 815 40 815 40 25. 2020 06 January 1, 2021, no In May 2021, ASU 2021 04, 2021 04 January 1, 2021, no In October 2021, ASU 2021 08, 2021 08 October 1, 2021 no Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation Use of Estimates Reclassifications no Cash and Cash Equivalents three may not not Accounts Receivable and Allowance for Doubtful Accounts may not Inventories Property and Equipment We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not not Goodwill fourth not may first not not may 2021 7, December 31, 2021. Intangible Assets, Exclusive of Goodwill may not may not not Leases We recognize right-of-use assets and lease liabilities based on the present value of the future minimum lease payments over the lease term, beginning at the commencement date, for leases exceeding a year. Minimum lease payments include the fixed lease components of the lease and any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Lease terms may In determining our right-of-use assets and lease liabilities, we apply a discount rate to the minimum lease payments within each lease. When we cannot readily determine the discount rate implicit in a lease, we utilize our incremental borrowing rate, the rate of interest that we would incur to borrow, on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. To estimate the incremental borrowing rate, we reference a market yield curve consistent with our assessment of our credit quality. We recognize operating lease expense related to the minimum lease payments on a straight-line basis over the lease term. For finance leases, we recognize amortization expense related to the minimum lease payments on a straight-line basis over the lease term while interest expense is recognized using the effective interest method. Expense related to variable lease payments that do not Revenue Recognition Revenue is measured as the amount of consideration we expect to receive in exchange for fulfilling product orders. Incidental items that are immaterial in the context of the contract are recognized as expense. Our contracts do not may Incremental costs of obtaining a revenue contract are capitalized and amortized on a straight-line basis over the expected customer relationship period if we expect to recover those costs. As a practical expedient, we expense costs to obtain a contract as incurred if the amortization period would have been a year or less. Typically, costs to incur revenue contracts are not Selling, General and Administrative Expenses Research and Development Share-Based Compensation For awards of nonvested stock to employees, share-based compensation is measured based on the fair value of the stock on the date of grant and the corresponding expense is recognized over the period during which an employee is required to provide service in exchange for the reward. Compensation expense related to service-based awards are recognized on a straight-line basis over the requisite service period for the entire award. For restricted stock units issued to employees with market conditions, share-based compensation is measured based on the fair value of the award on the date of grant using a binomial simulation model and expense is recognized over the derived service period determined by the simulation. The binomial simulation model requires us to estimate key assumptions such as stock volatility, risk-free interest rates and dividend yields based on both historical information and management’s judgment regarding market factors and trends. Share-based compensation for awards to nonemployees is calculated as of the grant date, taking into consideration the probability of satisfaction of performance conditions, in a manner consistent with awards to employees. The expense associated with share-based awards for service is recognized over the term of service. In the event services are terminated early or we require no Income Taxes Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards. A valuation allowance is established, when necessary, to reduce that deferred tax asset if it is more likely than not not may may may may no We recognize interest and penalties related to uncertain tax positions, if any, in selling, general and administrative expenses. Derivative Warrant Liability Fair Value may may We assess the inputs used to measure fair value using a three ● Level 1 ● Level 2 ● Level 3 not

Note 3 - Cash and Cash Equivale

Note 3 - Cash and Cash Equivalents	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Cash and Cash Equivalents Disclosure [Text Block]	NOTE 3. As of December 31, 2021, three We have cash on deposit in excess of federally insured limits at a bank. We do not

Note 4 - Accounts Receivable an

Note 4 - Accounts Receivable and Revenues	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Accounts Receivable and Revenues [Text Block}	NOTE 4. Amounts billed and due from our customers are classified as accounts receivables on our consolidated balance sheets and require payment on a short-term basis. Invoices are generally issued at the point control transfers and substantially all of our invoices are due within 30 120 30 2021 2020 Our accounts receivable potentially subject us to significant concentrations of credit risk. Revenues and accounts receivable from significant customers (customers with revenue or accounts receivable in excess of 10% Customer A B C % of revenue, 2021 5 % 11 % 12 % % of revenue, 2020 10 % 11 % 2 % % of accounts receivable, as of December 31, 2021 7 % 8 % 15 % % of accounts receivable, as of December 31, 2020 17 % 1 % 10 % The following table presents revenues by geographic area shipped to (in thousands). 2021 2020 United States $ 29,637 $ 24,790 Other countries 1,494 1,409 Revenues $ 31,131 $ 26,199

Note 5 - Inventories

Note 5 - Inventories	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 5. The following table details the components of inventories (in thousands). December 31 2021 2020 Finished goods $ 1,679 $ 1,512 Raw materials 599 236 Packaging 166 130 Inventories $ 2,444 $ 1,878

Note 6 - Property and Equipment

Note 6 - Property and Equipment	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 6. The following table details the components of property and equipment (amounts in thousands). December 31 2021 2020 Estimated Useful Lives (Years) Land $ 730 $ 730 Furniture and fixtures 265 276 5 - 10 Plant 10,457 9,377 20 - 40 or life of lease Computer and software 452 1,060 3 - 5 Leasehold improvements 1,828 1,880 4 - 15 or life of lease Machinery and equipment 15,115 16,402 5 - 15 Property and equipment, cost 28,847 29,725 Less accumulated depreciation 13,403 13,358 Property and equipment, net $ 15,444 $ 16,367 Amounts payable for property and equipment included in accounts payable totaled $0.2 million at December 31, 2021, December 31, 2020. not December 31, 2021, December 31, 2020. Involuntary Conversion In 2020, August 2020 September 2020, 2020. December 31, 2021, zero December 31, 2021, December 31, 2020. not first 2022. first 2022 2022

Note 7 - Intangible Assets and

Note 7 - Intangible Assets and Goodwill	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Goodwill and Intangible Assets Disclosure [Text Block]	NOTE 7. Intangible assets, excluding goodwill, consist of the following (in thousands). December 31, 2021 December 31, 2020 Estimated Useful Life Gross Carrying Value Accumulated Amortization Net Carrying Value Gross Carrying Value Accumulated Amortization Net Carrying Value Customer relationships 15 $ 930 $ 423 $ 507 $ 930 $ 236 $ 694 Trademarks 10 13 3 10 13 2 11 Non-compete agreement 5 22 12 10 22 8 14 Other 17 - - - 32 29 3 Total intangible assets $ 965 $ 438 $ 527 $ 997 $ 275 $ 722 The customer relationship intangible is amortizing over the 15-year period of expected future economic benefit, in proportion to the discounted expected future cash flows used to estimate the value of the intangible at acquisition in 2019. As of December 31, 2021, 2022 $ 147 2023 111 2024 80 2025 58 2026 42 Thereafter 89 Total amortization $ 527 A summary of goodwill activity follows (in thousands). 2021 2020 Goodwill, January 1 $ 3,915 $ 3,915 Impairment of goodwill (3,915 ) - Goodwill, December 31 $ - $ 3,915 We performed our annual impairment testing of goodwill as of December 31, 2021. fourth 2021,

Note 8 - Leases

Note 8 - Leases	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Lessee, Operating and Finance Leases [Text Block]	NOTE 8. The components of lease expense and cash flows from leases (in thousands) follow. 2021 2020 Finance lease cost: Amortization of right-of use assets, included in cost of goods sold $ 89 $ 62 Interest on lease liabilities 11 14 Operating lease cost, included in selling, general and administrative expenses: Fixed leases cost 515 517 Variable lease cost 149 127 Short-term lease cost 61 9 Total lease cost $ 825 $ 729 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 11 $ 14 Operating cash flows from operating leases $ 515 $ 517 Financing cash flows from finance leases $ 96 $ 101 As of December 31, 2021, not December 31, 2021, 2021, 2020, As of December 31, 2021, not December 31, 2021, Operating Leases Finance Leases Remaining leases terms (in years) 1.8 - 11.2 0.4 - 4.8 Weighted average remaining lease terms (in years) 6.2 2.6 Discount rates 6.3% - 9.0% 2.8% - 7.3% Weighted average discount rate 7.7% 4.9% As of December 31, 2021, 2032. December 31, 2021, Operating Finance Leases Leases 2022 $ 548 $ 93 2023 528 63 2024 429 23 2025 439 9 2026 451 7 Thereafter 578 - Total lease payments 2,973 195 Amounts representing interest (643 ) (9 ) Present value of lease obligations $ 2,330 $ 186

Note 9 - Debt

Note 9 - Debt	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 9. We finance certain amounts owed for annual insurance premiums under financing agreements. As of December 31, 2021, February 2022, In October 2019, may two October 2022. two October 2021. no Due under factoring agreement consists of the following (in thousands). December 31, 2021 2020 Borrowings outstanding $ 3,379 $ 1,860 Debt issuance costs, net - (75 ) Due under factoring agreement $ 3,379 $ 1,785 Additional information related to our factoring obligation follows. 2021 2020 Average borrowings outstanding (in thousands) $ 1,622 $ 1,713 Amortization of debt issuance costs (in thousands) $ 75 $ 91 Fees paid, as a percentage of average oustanding borrowings 6.2 % 7.3 % Interest paid, as a percentage of average outstanding borrowings 6.4 % 6.4 % Long-term debt consists of the following (in thousands). December 31, 2021 2020 Mortgage promissory note - Originally dated in July 2020 and modified in December 2021. As modified, interest accrues at an annual rate which is the greater of 7.0% 10.3% 10.3% 32 2.5 $ 2,469 $ 1,817 Payroll Protection Program note - Dated April 2020. Interest accrued at an annual rate of 1.0% - 1,792 Equipment note - Dated May 2021. Original principal $ 46 3.6% 33 - Equipment note - Dated December 2019. Original principal $ 40 9.3% 26 33 Equipment notes - Initially recorded in November 2018, in an acquisition, at the present value of future payments using a discount rate of 4.8% 11 37 Total long term debt, net $ 2,539 $ 3,679 In December 2021, 1ender’s May 2022 June 2022. In April 2020, March 2020. December 31 2020, January 2021. 14, Future principal maturities of long-term debt outstanding at December 31, 2021, 2022 $ 1,215 2023 1,332 2024 19 2025 5 Principal maturities 2,571 Debt issuance costs (32 ) Total long term debt, net $ 2,539

Note 10 - Equity, Share-based C

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Shareholders' Equity and Share-based Payments [Text Block]	NOTE 10. In June 2020, Preferred Stock Our board of directors, without further action or vote by holders of our common stock, has the right to establish the terms, preference, rights and restrictions and issue shares of preferred stock. We previously designated and issued six seventh December 31, 2021. The Series G preferred stock is non-voting and may 1 Securities Offerings In September 2021, 3. September 2022, September 2023, 5 2021, not may September 13, 2021, 2,307,855 September 13, 2021, September 2021 may On March 30, 2020, 3. 2021, 2021 2020, 2020 September 2021 September 13, 2023. Equity Incentive Plan Our board of directors adopted our 2014 2014 August 2014, 2014 may may December 31, 2021, 2014 December 31, 2021, December 15, 2022. Share-based compensation expenses related to employees and directors are included in selling, general and administrative expenses. Share-based compensation by type of award follows (in thousands). 2021 2020 Common stock $ 108 $ 308 Stock options 140 148 Restricted stock units 866 585 Compensation expense related to common stock awards issued under equity incentive plan $ 1,114 $ 1,041 Information regarding common stock issued under the equity incentive plan follows, including shares issued upon vesting of restricted stock units. All shares of common stock issued in 2021 2020 2021 2020 Shares Issued Weighted Average Grant Date Fair Value Per Share Shares Issued Weighted Average Grant Date Fair Value Per Share Directors 136,084 $ 0.80 83,306 $ 0.53 Employees 572,500 0.55 71,011 0.85 Consultants - 59,917 0.71 708,584 214,234 The shares of common stock issued to employees in 2021 Options Stock option activity follows. 2021 2020 Shares Under Options Weighted Average Exercise Price Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Life (Years) Shares Under Options Weighted Average Exercise Price Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Life (Years) Outstanding at January 1 675,026 $ 2.24 7.9 996,009 $ 3.23 8.1 Granted - - NA - 653,004 1.22 $ 0.73 10.0 Forfeited (31,067 ) 8.40 7.4 (973,987 ) 2.56 8.1 Outstanding at December 31 643,959 $ 1.95 6.9 675,026 $ 2.24 7.9 The options granted in 2020 three four Information related to outstanding and exercisable stock options as of December 31, 2021, Outstanding Exercisable Range of Exercise Prices Shares Underlying Options Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Shares Underlying Options Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) less than $1.00 78,000 $ 0.85 5.3 78,000 $ 0.85 5.3 $1.00 to $1.99 333,811 1.26 7.7 115,983 1.32 7.2 $2.00 to $2.99 116,750 2.79 7.3 72,687 2.82 7.1 $3.00 to $3.99 89,875 3.34 6.3 60,256 3.36 5.9 $4.00 to $4.99 23,104 4.43 2.6 23,094 4.43 2.6 $5.00 to $16.00 2,419 16.00 0.8 2,419 16.00 0.8 643,959 $ 1.95 6.9 352,439 $ 2.18 6.2 As of December 31, 2021, December 31, 2020, 2020 Assumed volatility 60% - 69% (62% weighted average) Assumed risk free interest rate 1.3% - 1.7% (1.6% weighted average) Average expected life of options (in years) 5.9 - 7.0 (6.3 weighted average) Expected dividends - Restricted Stock Units Restricted stock unit (RSU) activity follows. 2021 2020 RSU Shares Issued Unrecognized Stock Compensation (in thousands) Weighted Average Expense Period (Years) RSU Shares Issued Unrecognized Stock Compensation (in thousands) Weighted Average Expense Period (Years) Nonvested at January 1 1,495,400 $ 730 1.4 1,148,062 $ 377 1. 4 Granted (1) 824,689 796 1.0 1,261,803 828 0.9 Modified - - - - Before modification (2) - - (227,062 ) (22 ) After modification (3) - - 620,000 353 2.0 Vested (4) (1,051,149 ) - (386,403 ) - Cancelled - - (625,000 ) - Forfeited (5) (2,907 ) (3 ) (296,000 ) (221 ) Expensed - (865 ) - (585 ) Nonvested at December 31 1,266,033 $ 658 0.9 1,495,400 $ 730 1.4 ( 1 The shares of common stock subject to the RSUs granted in 2021 2020, two not 2020, 2019 sixty-five fifth ( 2 In December 2020, sixty-five one fifth October 2023 August 2024. ( 3 In December 2020, December 2021 December 2022. two ( 4 Represents the following. 2021 2020 Vested when granted 386,403 386,403 Vested upon completion of service conditions, common stock issued at vesting 572,500 - Vested upon completion of service, common stock issuance deferred 450,400 - Outstanding at December 31 1,409,303 386,403 ( 5 In 2021 2020, As of December 31, 2021, no In addition, as of December 31, 2021, 2014 Warrants Prefunded Warrant was cashless exercised in its entirety in 2021 2021 2020 Shares Under Warrants Weighted Averag e Exercise Price Weighted Average Remaining Contractual Life (Years) Shares Under Warrants Weighted Average Exercis e Price Weighted Average Remaining Contractual Life (Years) Outstanding at January 1 6,645,916 $ 0.98 1.1 7,532,280 $ 1.32 1.9 Granted (1) 2,307,693 1.00 5.0 - NA NA Cash exercised (177,936 ) 0.96 0.8 (12,948 ) 0.96 - Cashless exercised (2) - NA NA (215,740 ) 0.96 - Expired (25,000 ) 5.25 - (657,676 ) 5.25 - Outstanding at December 31 (2) 8,750,673 $ 0.98 1.4 6,645,916 $ 0.98 1.1 ( 1 Represents Warrant A and is classified as a liability in our consolidated balance sheets. The $1.00 per share exercise price as of December 31, 2021, September 2022, September 2023, 5 ( 2 We issued 54,629 shares of common stock upon the cashless exercise of the warrants in 2020. ( 3 Under the terms of certain outstanding warrants, the holders may December 31, 2021, may may no may As of December 31, 2021, December 31, 2021. Range of Exercise Prices Shares Under Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) $ 0.96 6,392,980 $ 0.96 0.1 $ 1.00 (1) 2,307,693 1.00 4.7 $ 2.00 50,000 2.00 1.1 8,750,673 $ 0.98 1.4 ( 1 Represents Warrant A and is classified as a liability in our consolidated balance sheets because the holder may December 31, 2021, September 2022, September 2023, 5 In February 2022, In the period from January 1, 2022 March 17, 2022, ● issued RSUs under the 2014 March 2023, ● awarded 1,898,781 RSUs to employees that are subject to our shareholders approving an increase in the total shares of common stock authorized for issuance under the 2014 ● issued 224,751 shares of common stock upon the vesting of RSUs with an average grant date fair value of $0.91 per share.

Note 11 - Income Taxes

Note 11 - Income Taxes	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 11. Deferred tax asset (liability) is comprised of the following (in thousands): December 31 2021 2020 Net operating loss carryforwards $ 13,385 $ 11,473 Stock options and warrants 832 576 Property and equipment 16 50 Intangible assets 950 (9 ) Capitalized expenses 105 85 Other 64 135 Operating right-of-use lease assets (566 ) (652 ) Operating right-of-use lease liabilities 670 763 Net deferred tax assets 15,456 12,421 Less: Valuation allowance (15,456 ) (12,421 ) Deferred tax asset (liability) $ - $ - We have determined it is more likely than not not The following table summarizes the change in the valuation allowance (in thousands): 2021 2020 Vaulation allowances, beginning of year $ 12,421 $ 8,687 Net operating loss and other temporary differences 2,926 3,039 Expiration of net operating losses and limitations - (20 ) Adjustment to deferred taxes 67 (51 ) Impact of state tax rate change 42 746 Other adjusments - 20 Valuation allowance, end of year $ 15,456 $ 12,421 As of December 31, 2021, December 31, 2017, not 2022 2037 not December 31, 2021, 2022 2041. Our ability to utilize previously accumulated NOL carryforwards is subject to substantial annual limitations due to the changes in ownership provisions of the Internal Revenue Code (IRC) of 1986, 2020, 382 may We are subject to taxation in the U.S. federal jurisdiction and various state and local jurisdictions. We record liabilities for income tax contingencies based on our best estimate of the underlying exposures. We are open for audit by the IRS for years after 2017 2016. Reconciliations between the amounts computed by applying the U.S. federal statutory tax rate to loss before income taxes, and income tax expense (benefit) follows (in thousands): 2021 2020 Income tax benefit at federal statutory rate $ (1,875 ) $ (2,459 ) Increase (decrease) resulting from: State tax benefit, net of federal tax effect (605 ) (623 ) Effect of change in state tax rate (42 ) (746 ) Change in valuation allowance 3,035 3,734 Expirations of net operating losses and application of IRC 382 limitation - 20 PPP loan forgiveness, nontaxable (376 ) - Change in fair value of derivative warrant liability, nontaxable (81 ) - Other nondeductible expenses 32 - Adjustments to deferreds (67 ) 51 Other - 42 Income tax expense $ 21 $ 19 Based on an analysis of tax positions taken on income tax returns filed, we determined no December 31, 2021 2020. may

Note 12 - Income (Loss) Per Sha

Note 12 - Income (Loss) Per Share (EPS)	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Earnings Per Share [Text Block]	NOTE 12. Basic EPS is calculated under the two may not Diluted EPS is computed by dividing the net income attributable to RiceBran Technologies common shareholders by the weighted average number of common shares outstanding during the period increased by the number of additional common shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive. The dilutive effects of outstanding options, warrants, nonvested shares of common stock and nonvested restricted stock units that vest solely on the basis of a service condition are calculated using the treasury stock method. The dilutive effects of the outstanding preferred stock are calculated using the if-converted method. Below are reconciliations of the numerators and denominators in the EPS computations. 2021 2020 NUMERATOR (in thousands): Basic and diluted - net loss $ (8,949 ) $ (11,730 ) DENOMINATOR: Weighted average number of shares of shares of common stock outstanding 47,105,673 41,019,802 Weighted average number of shares of common stock underlying vested restricted stock units 633,275 111,980 Basic EPS - weighted average number of shares outstanding 47,738,948 41,131,782 Effect of dilutive securities outstanding - - Diluted EPS - weighted average number of shares outstanding 47,738,948 41,131,782 No 2021 2020, 2021 2020 10,

Note 13 - Fair Value Measuremen

Note 13 - Fair Value Measurement	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Fair Value Disclosures [Text Block]	NOTE 13. The fair value of cash and cash equivalents, restricted cash, accounts and other receivables, accounts payable, commodities payable and short-term debt approximated their carrying value due to shorter maturities. As of December 31, 2021, 3 December 31, 2021, 3 The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our consolidated balance sheets (in thousands): Level 1 Level 2 Level 3 Total Derivative warrant liability $ - $ - $ 258 $ 258 Total liabilities at fair value $ - $ - $ 258 $ 258 The following tables summarize the changes in level 3 2021 Fair Value as of Beginning of Period Total Realized and Unrealized Gains (Losses) Issuance of New Instruments Net Transfers (Into) Out of Level 3 Fair Value, at End of Period Change in Unrealized Gains (Losses) on Instruments Still Held Derivative warrant liability $ - $ - $ 647 $ - $ 258 $ (389 ) Total Level 3 fair value $ - $ - $ 647 $ - $ 258 $ (389 ) The derivative warrant liability relates to Warrant A, discussed further in Note 10. may December 31, 2021, December 31, 2021 September 30, 2021 Assumed volatility 69.5 % 71.0 % Assumed risk free interest rate 0.8 % 0.4 % Expected life of options (in years) 4.8 5.0 Expected dividends - - The fair value of Warrant A approximates the cash settlement the holder could elect to be paid in the event of a change in control. At December 31, 2021,

Note 14 - Commitments and Conti

Note 14 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 14. PPP Audit Contingency As discussed in Note 9, January 2021. may January 2027, six may 2020 $2 Employment Contracts and Severance Payments In the normal course of business, we periodically enter into employment agreements which incorporate indemnification provisions. While the maximum amount to which we may No We have employment contracts with certain officers and key management that include provisions for potential severance payments in the event of without-cause terminations or terminations under certain circumstances after a change in control. In addition, vesting of outstanding nonvested equity grants would accelerate following a change in control. Legal Matters From time to time, we are involved in litigation incidental to the conduct of our business. These matters may no 2021 2020, 2020. 2020,

Note 15 - Related Party Transac

Note 15 - Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 15. Our director, Ari Gendason, is an employee and senior vice president and chief investment officer of Continental Grain Company (CGC). As of the date of this filing, CGC owns approximately 20.6% of our outstanding common stock. We have agreed that in connection with each annual or special meeting of our shareholders at which members of our board of directors are to be elected, or any written consent of our shareholders pursuant to which members of the board of directors are to be elected, CGC shall have the right to designate one

Note 16 - Failure to Comply wit

Note 16 - Failure to Comply with NASDAQ Listing Requirements	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Failure to Comply with Nasdaq Listing Requirements Disclosure [Text Block]	NOTE 16. On September 15, 2021, 5550 2 5550 2 $1.00. $1.00 10, not 20, not 180 September 12, 2022. $1.00

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Segment Reporting, Policy [Policy Text Block]	Segment Reporting An operating segment is defined as a component of a business for which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and evaluate performance. The “Segment Reporting” topic of the Financial Accounting Standard Board (FASB) accounting standards codification requires that public companies report certain information about operating segments. It also requires that public companies report certain information about their products and services, the geographic areas in which they operate, and their major customers. Given the integrated nature of these facilities, we have one one
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Guidance Recent accounting standards not The following discusses the accounting standard(s) not In June 2016, ASU No. 2016 13 Financial Instruments Credit Losses (Topic 326 Measurement of Credit Losses on Financial Instruments 2023 January 1, 2023. not Recently adopted accounting standards In August 2020, ASU 2020 06, 470 20 Contracts in Entity s Own Equity (Subtopic 815 40 815 40 25. 2020 06 January 1, 2021, no In May 2021, ASU 2021 04, 2021 04 January 1, 2021, no In October 2021, ASU 2021 08, 2021 08 October 1, 2021 no
Consolidation, Policy [Policy Text Block]	Basis of Presentation and Principles of Consolidation
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
Reclassification, Comparability Adjustment [Policy Text Block]	Reclassifications no
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents three may not not
Accounts Receivable [Policy Text Block]	Accounts Receivable and Allowance for Doubtful Accounts may not
Inventory, Policy [Policy Text Block]	Inventories
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not not
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill fourth not may first not not may 2021 7, December 31, 2021.
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Intangible Assets, Exclusive of Goodwill may not may not not
Lessee, Leases [Policy Text Block]	Leases We recognize right-of-use assets and lease liabilities based on the present value of the future minimum lease payments over the lease term, beginning at the commencement date, for leases exceeding a year. Minimum lease payments include the fixed lease components of the lease and any variable rate payments that depend on an index, initially measured using the index at the lease commencement date. Lease terms may In determining our right-of-use assets and lease liabilities, we apply a discount rate to the minimum lease payments within each lease. When we cannot readily determine the discount rate implicit in a lease, we utilize our incremental borrowing rate, the rate of interest that we would incur to borrow, on a collateralized basis over a similar term, an amount equal to the lease payments in a similar economic environment. To estimate the incremental borrowing rate, we reference a market yield curve consistent with our assessment of our credit quality. We recognize operating lease expense related to the minimum lease payments on a straight-line basis over the lease term. For finance leases, we recognize amortization expense related to the minimum lease payments on a straight-line basis over the lease term while interest expense is recognized using the effective interest method. Expense related to variable lease payments that do not
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition Revenue is measured as the amount of consideration we expect to receive in exchange for fulfilling product orders. Incidental items that are immaterial in the context of the contract are recognized as expense. Our contracts do not may Incremental costs of obtaining a revenue contract are capitalized and amortized on a straight-line basis over the expected customer relationship period if we expect to recover those costs. As a practical expedient, we expense costs to obtain a contract as incurred if the amortization period would have been a year or less. Typically, costs to incur revenue contracts are not
Selling, General and Administrative Expenses, Policy [Policy Text Block]	Selling, General and Administrative Expenses
Research, Development, and Computer Software, Policy [Policy Text Block]	Research and Development
Share-based Payment Arrangement, Director [Policy Text Block]	Share-Based Compensation For awards of nonvested stock to employees, share-based compensation is measured based on the fair value of the stock on the date of grant and the corresponding expense is recognized over the period during which an employee is required to provide service in exchange for the reward. Compensation expense related to service-based awards are recognized on a straight-line basis over the requisite service period for the entire award. For restricted stock units issued to employees with market conditions, share-based compensation is measured based on the fair value of the award on the date of grant using a binomial simulation model and expense is recognized over the derived service period determined by the simulation. The binomial simulation model requires us to estimate key assumptions such as stock volatility, risk-free interest rates and dividend yields based on both historical information and management’s judgment regarding market factors and trends. Share-based compensation for awards to nonemployees is calculated as of the grant date, taking into consideration the probability of satisfaction of performance conditions, in a manner consistent with awards to employees. The expense associated with share-based awards for service is recognized over the term of service. In the event services are terminated early or we require no
Derivatives, Policy [Policy Text Block]	Income Taxes Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards. A valuation allowance is established, when necessary, to reduce that deferred tax asset if it is more likely than not not may may may may no We recognize interest and penalties related to uncertain tax positions, if any, in selling, general and administrative expenses.
Income Tax, Policy [Policy Text Block]	Derivative Warrant Liability
Fair Value Measurement, Policy [Policy Text Block]	Fair Value may may We assess the inputs used to measure fair value using a three ● Level 1 ● Level 2 ● Level 3 not

Note 4 - Accounts Receivable _2

Note 4 - Accounts Receivable and Revenues (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Customer A B C % of revenue, 2021 5 % 11 % 12 % % of revenue, 2020 10 % 11 % 2 % % of accounts receivable, as of December 31, 2021 7 % 8 % 15 % % of accounts receivable, as of December 31, 2020 17 % 1 % 10 %
Disaggregation of Revenue [Table Text Block]	2021 2020 United States $ 29,637 $ 24,790 Other countries 1,494 1,409 Revenues $ 31,131 $ 26,199

Note 5 - Inventories (Tables)

Note 5 - Inventories (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31 2021 2020 Finished goods $ 1,679 $ 1,512 Raw materials 599 236 Packaging 166 130 Inventories $ 2,444 $ 1,878

Note 6 - Property and Equipme_2

Note 6 - Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Property, Plant and Equipment [Table Text Block]	December 31 2021 2020 Estimated Useful Lives (Years) Land $ 730 $ 730 Furniture and fixtures 265 276 5 - 10 Plant 10,457 9,377 20 - 40 or life of lease Computer and software 452 1,060 3 - 5 Leasehold improvements 1,828 1,880 4 - 15 or life of lease Machinery and equipment 15,115 16,402 5 - 15 Property and equipment, cost 28,847 29,725 Less accumulated depreciation 13,403 13,358 Property and equipment, net $ 15,444 $ 16,367

Note 7 - Intangible Assets an_2

Note 7 - Intangible Assets and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	December 31, 2021 December 31, 2020 Estimated Useful Life Gross Carrying Value Accumulated Amortization Net Carrying Value Gross Carrying Value Accumulated Amortization Net Carrying Value Customer relationships 15 $ 930 $ 423 $ 507 $ 930 $ 236 $ 694 Trademarks 10 13 3 10 13 2 11 Non-compete agreement 5 22 12 10 22 8 14 Other 17 - - - 32 29 3 Total intangible assets $ 965 $ 438 $ 527 $ 997 $ 275 $ 722
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2022 $ 147 2023 111 2024 80 2025 58 2026 42 Thereafter 89 Total amortization $ 527
Schedule of Goodwill [Table Text Block]	2021 2020 Goodwill, January 1 $ 3,915 $ 3,915 Impairment of goodwill (3,915 ) - Goodwill, December 31 $ - $ 3,915

Note 8 - Leases (Tables)

Note 8 - Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Lease, Cost [Table Text Block]	2021 2020 Finance lease cost: Amortization of right-of use assets, included in cost of goods sold $ 89 $ 62 Interest on lease liabilities 11 14 Operating lease cost, included in selling, general and administrative expenses: Fixed leases cost 515 517 Variable lease cost 149 127 Short-term lease cost 61 9 Total lease cost $ 825 $ 729 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from finance leases $ 11 $ 14 Operating cash flows from operating leases $ 515 $ 517 Financing cash flows from finance leases $ 96 $ 101
Lessee, Operating and Finance Leases, Remaining Terms and Discount Rates [Table Text Block]	Operating Leases Finance Leases Remaining leases terms (in years) 1.8 - 11.2 0.4 - 4.8 Weighted average remaining lease terms (in years) 6.2 2.6 Discount rates 6.3% - 9.0% 2.8% - 7.3% Weighted average discount rate 7.7% 4.9%
Lessee, Operating and Finance Lease Liability, Maturity [Table Text Block]	Operating Finance Leases Leases 2022 $ 548 $ 93 2023 528 63 2024 429 23 2025 439 9 2026 451 7 Thereafter 578 - Total lease payments 2,973 195 Amounts representing interest (643 ) (9 ) Present value of lease obligations $ 2,330 $ 186

Note 9 - Debt (Tables)

Note 9 - Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Debt [Table Text Block]	December 31, 2021 2020 Borrowings outstanding $ 3,379 $ 1,860 Debt issuance costs, net - (75 ) Due under factoring agreement $ 3,379 $ 1,785 2021 2020 Average borrowings outstanding (in thousands) $ 1,622 $ 1,713 Amortization of debt issuance costs (in thousands) $ 75 $ 91 Fees paid, as a percentage of average oustanding borrowings 6.2 % 7.3 % Interest paid, as a percentage of average outstanding borrowings 6.4 % 6.4 %
Schedule of Long-term Debt Instruments [Table Text Block]	December 31, 2021 2020 Mortgage promissory note - Originally dated in July 2020 and modified in December 2021. As modified, interest accrues at an annual rate which is the greater of 7.0% 10.3% 10.3% 32 2.5 $ 2,469 $ 1,817 Payroll Protection Program note - Dated April 2020. Interest accrued at an annual rate of 1.0% - 1,792 Equipment note - Dated May 2021. Original principal $ 46 3.6% 33 - Equipment note - Dated December 2019. Original principal $ 40 9.3% 26 33 Equipment notes - Initially recorded in November 2018, in an acquisition, at the present value of future payments using a discount rate of 4.8% 11 37 Total long term debt, net $ 2,539 $ 3,679
Schedule of Maturities of Long-term Debt [Table Text Block]	2022 $ 1,215 2023 1,332 2024 19 2025 5 Principal maturities 2,571 Debt issuance costs (32 ) Total long term debt, net $ 2,539

Note 10 - Equity, Share-based_2

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	2021 2020 Common stock $ 108 $ 308 Stock options 140 148 Restricted stock units 866 585 Compensation expense related to common stock awards issued under equity incentive plan $ 1,114 $ 1,041
Share-based Payment Arrangement, Activity [Table Text Block]	2021 2020 Shares Issued Weighted Average Grant Date Fair Value Per Share Shares Issued Weighted Average Grant Date Fair Value Per Share Directors 136,084 $ 0.80 83,306 $ 0.53 Employees 572,500 0.55 71,011 0.85 Consultants - 59,917 0.71 708,584 214,234
Share-based Payment Arrangement, Option, Activity [Table Text Block]	2021 2020 Shares Under Options Weighted Average Exercise Price Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Life (Years) Shares Under Options Weighted Average Exercise Price Weighted Average Grant Date Fair Value Weighted Average Remaining Contractual Life (Years) Outstanding at January 1 675,026 $ 2.24 7.9 996,009 $ 3.23 8.1 Granted - - NA - 653,004 1.22 $ 0.73 10.0 Forfeited (31,067 ) 8.40 7.4 (973,987 ) 2.56 8.1 Outstanding at December 31 643,959 $ 1.95 6.9 675,026 $ 2.24 7.9
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	Outstanding Exercisable Range of Exercise Prices Shares Underlying Options Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) Shares Underlying Options Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) less than $1.00 78,000 $ 0.85 5.3 78,000 $ 0.85 5.3 $1.00 to $1.99 333,811 1.26 7.7 115,983 1.32 7.2 $2.00 to $2.99 116,750 2.79 7.3 72,687 2.82 7.1 $3.00 to $3.99 89,875 3.34 6.3 60,256 3.36 5.9 $4.00 to $4.99 23,104 4.43 2.6 23,094 4.43 2.6 $5.00 to $16.00 2,419 16.00 0.8 2,419 16.00 0.8 643,959 $ 1.95 6.9 352,439 $ 2.18 6.2
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	2020 Assumed volatility 60% - 69% (62% weighted average) Assumed risk free interest rate 1.3% - 1.7% (1.6% weighted average) Average expected life of options (in years) 5.9 - 7.0 (6.3 weighted average) Expected dividends -
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]	2021 2020 RSU Shares Issued Unrecognized Stock Compensation (in thousands) Weighted Average Expense Period (Years) RSU Shares Issued Unrecognized Stock Compensation (in thousands) Weighted Average Expense Period (Years) Nonvested at January 1 1,495,400 $ 730 1.4 1,148,062 $ 377 1. 4 Granted (1) 824,689 796 1.0 1,261,803 828 0.9 Modified - - - - Before modification (2) - - (227,062 ) (22 ) After modification (3) - - 620,000 353 2.0 Vested (4) (1,051,149 ) - (386,403 ) - Cancelled - - (625,000 ) - Forfeited (5) (2,907 ) (3 ) (296,000 ) (221 ) Expensed - (865 ) - (585 ) Nonvested at December 31 1,266,033 $ 658 0.9 1,495,400 $ 730 1.4
Nonvested Restricted Stock Shares Activity [Table Text Block]	2021 2020 Vested when granted 386,403 386,403 Vested upon completion of service conditions, common stock issued at vesting 572,500 - Vested upon completion of service, common stock issuance deferred 450,400 - Outstanding at December 31 1,409,303 386,403
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	2021 2020 Shares Under Warrants Weighted Averag e Exercise Price Weighted Average Remaining Contractual Life (Years) Shares Under Warrants Weighted Average Exercis e Price Weighted Average Remaining Contractual Life (Years) Outstanding at January 1 6,645,916 $ 0.98 1.1 7,532,280 $ 1.32 1.9 Granted (1) 2,307,693 1.00 5.0 - NA NA Cash exercised (177,936 ) 0.96 0.8 (12,948 ) 0.96 - Cashless exercised (2) - NA NA (215,740 ) 0.96 - Expired (25,000 ) 5.25 - (657,676 ) 5.25 - Outstanding at December 31 (2) 8,750,673 $ 0.98 1.4 6,645,916 $ 0.98 1.1
Schedule of Share-based Compensation Warrants by Exercise Price Range [Table Text Block ]	Range of Exercise Prices Shares Under Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Life (Years) $ 0.96 6,392,980 $ 0.96 0.1 $ 1.00 (1) 2,307,693 1.00 4.7 $ 2.00 50,000 2.00 1.1 8,750,673 $ 0.98 1.4

Note 11 - Income Taxes (Tables)

Note 11 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31 2021 2020 Net operating loss carryforwards $ 13,385 $ 11,473 Stock options and warrants 832 576 Property and equipment 16 50 Intangible assets 950 (9 ) Capitalized expenses 105 85 Other 64 135 Operating right-of-use lease assets (566 ) (652 ) Operating right-of-use lease liabilities 670 763 Net deferred tax assets 15,456 12,421 Less: Valuation allowance (15,456 ) (12,421 ) Deferred tax asset (liability) $ - $ -
Summary of Valuation Allowance [Table Text Block]	2021 2020 Vaulation allowances, beginning of year $ 12,421 $ 8,687 Net operating loss and other temporary differences 2,926 3,039 Expiration of net operating losses and limitations - (20 ) Adjustment to deferred taxes 67 (51 ) Impact of state tax rate change 42 746 Other adjusments - 20 Valuation allowance, end of year $ 15,456 $ 12,421
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]	2021 2020 Income tax benefit at federal statutory rate $ (1,875 ) $ (2,459 ) Increase (decrease) resulting from: State tax benefit, net of federal tax effect (605 ) (623 ) Effect of change in state tax rate (42 ) (746 ) Change in valuation allowance 3,035 3,734 Expirations of net operating losses and application of IRC 382 limitation - 20 PPP loan forgiveness, nontaxable (376 ) - Change in fair value of derivative warrant liability, nontaxable (81 ) - Other nondeductible expenses 32 - Adjustments to deferreds (67 ) 51 Other - 42 Income tax expense $ 21 $ 19

Note 12 - Income (Loss) Per S_2

Note 12 - Income (Loss) Per Share (EPS) (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	2021 2020 NUMERATOR (in thousands): Basic and diluted - net loss $ (8,949 ) $ (11,730 ) DENOMINATOR: Weighted average number of shares of shares of common stock outstanding 47,105,673 41,019,802 Weighted average number of shares of common stock underlying vested restricted stock units 633,275 111,980 Basic EPS - weighted average number of shares outstanding 47,738,948 41,131,782 Effect of dilutive securities outstanding - - Diluted EPS - weighted average number of shares outstanding 47,738,948 41,131,782

Note 13 - Fair Value Measurem_2

Note 13 - Fair Value Measurement (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]	Level 1 Level 2 Level 3 Total Derivative warrant liability $ - $ - $ 258 $ 258 Total liabilities at fair value $ - $ - $ 258 $ 258
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Fair Value as of Beginning of Period Total Realized and Unrealized Gains (Losses) Issuance of New Instruments Net Transfers (Into) Out of Level 3 Fair Value, at End of Period Change in Unrealized Gains (Losses) on Instruments Still Held Derivative warrant liability $ - $ - $ 647 $ - $ 258 $ (389 ) Total Level 3 fair value $ - $ - $ 647 $ - $ 258 $ (389 )
Warrants, Valuation Assumption [Table Text Block]	December 31, 2021 September 30, 2021 Assumed volatility 69.5 % 71.0 % Assumed risk free interest rate 0.8 % 0.4 % Expected life of options (in years) 4.8 5.0 Expected dividends - -

Note 1 - Liquidity and Manage_2

Note 1 - Liquidity and Management's Plan (Details Textual) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 5,825	$ 5,825	$ 5,263
Percentage of Reduction in Selling, General and Administrative Expense		11.00%
Proceeds from Issuance or Sale of Equity, Total	3,600
Proceeds from Warrant Exercises	200	$ 171	$ 12
Direct Placement [Member]
Proceeds from Issuance or Sale of Equity, Total	2,800
At-the-market Offering Program [Member]
Proceeds from Issuance or Sale of Equity, Total	$ 600

Note 2 - Business and Summary_2

Note 2 - Business and Summary of Significant Accounting Policies (Details Textual) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Number of Reporting Units	1
Number of Operating Segments	1
Goodwill, Ending Balance	$ 0	$ 3,915	$ 3,915
Stabilized Rice Bran (SRB) [Member]
Number of Manufacturing and Distribution Locations	4
Stabilized Rice Bran (SRB) [Member] | CALIFORNIA
Number of Manufacturing and Distribution Locations	2
Stabilized Rice Bran (SRB) [Member] | LOUISIANA
Number of Manufacturing and Distribution Locations	1

Note 3 - Cash and Cash Equiva_2

Note 3 - Cash and Cash Equivalents (Details Textual) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 5,825	$ 5,263
Money Market Funds [Member]
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 4,300

Note 4 - Accounts Receivable _3

Note 4 - Accounts Receivable and Revenues (Details Textual) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Contract with Customer, Liability, Total	$ 0.1	$ 0.1

Note 4 - Accounts Receivable _4

Note 4 - Accounts Receivable and Revenues - Revenues and Accounts Receivable from Significant Customers (Details) - Customer Concentration Risk [Member]	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenue Benchmark [Member] | Customer A [Member]
Concentration risk, percentage	5.00%	10.00%
Revenue Benchmark [Member] | Customer B [Member]
Concentration risk, percentage	11.00%	11.00%
Revenue Benchmark [Member] | Customer C [Member]
Concentration risk, percentage	12.00%	2.00%
Accounts Receivable [Member] | Customer A [Member]
Concentration risk, percentage	7.00%	17.00%
Accounts Receivable [Member] | Customer B [Member]
Concentration risk, percentage	8.00%	1.00%
Accounts Receivable [Member] | Customer C [Member]
Concentration risk, percentage	15.00%	10.00%

Note 4 - Accounts Receivable _5

Note 4 - Accounts Receivable and Revenues - Revenues by Product Line (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenues	$ 31,131	$ 26,199
UNITED STATES
Revenues	29,637	24,790
Other Countries [Member]
Revenues	$ 1,494	$ 1,409

Note 5 - Inventories - Componen

Note 5 - Inventories - Components of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Finished goods	$ 1,679	$ 1,512
Raw materials	599	236
Packaging	166	130
Inventories	$ 2,444	$ 1,878

Note 6 - Property and Equipme_3

Note 6 - Property and Equipment (Details Textual) - USD ($) $ in Thousands	3 Months Ended	4 Months Ended	6 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Construction Payable, Current		$ 300	$ 300	$ 200	$ 300
Construction in Progress, Gross		600	600	900	600
Unusual or Infrequent Item, or Both, Loss, Gross			100
Unusual or Infrequent Item or Both Other Costs		100
Charges Deductible Under Insurance Policy		100
Proceeds from Insurance Settlement, Investing Activities				900
Insurance Settlement Accrued Receivable		700	$ 700	$ 0	700
Estimated Change in Unusual or Infrequent Item, Loss, Gross					$ 100
Forecast [Member]
Proceeds from Insurance Settlement, Investing Activities	$ 100
Natural Disasters and Other Casualty Events [Member]
Unusual or Infrequent Item, or Both, Loss, Gross		$ 900

Note 6 - Property and Equipme_4

Note 6 - Property and Equipment - Property, Plant and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property, plant, and equipment gross	$ 28,847	$ 29,725
Property, plant, and equipment accumulated depreciation	13,403	13,358
Property and equipment, net	15,444	16,367
Land [Member]
Property, plant, and equipment gross	730	730
Furniture and Fixtures [Member]
Property, plant, and equipment gross	$ 265	276
Furniture and Fixtures [Member] | Minimum [Member]
Estimated useful lives (Year)	5 years
Furniture and Fixtures [Member] | Maximum [Member]
Estimated useful lives (Year)	10 years
Plant [Member]
Property, plant, and equipment gross	$ 10,457	9,377
Plant [Member] | Minimum [Member]
Estimated useful lives (Year)	20 years
Plant [Member] | Maximum [Member]
Estimated useful lives (Year)	40 years
Computer and Software [Member]
Property, plant, and equipment gross	$ 452	1,060
Computer and Software [Member] | Minimum [Member]
Estimated useful lives (Year)	3 years
Computer and Software [Member] | Maximum [Member]
Estimated useful lives (Year)	5 years
Leasehold Improvements [Member]
Property, plant, and equipment gross	$ 1,828	1,880
Leasehold Improvements [Member] | Minimum [Member]
Estimated useful lives (Year)	4 years
Leasehold Improvements [Member] | Maximum [Member]
Estimated useful lives (Year)	15 years
Machinery and Equipment [Member]
Property, plant, and equipment gross	$ 15,115	$ 16,402
Machinery and Equipment [Member] | Minimum [Member]
Estimated useful lives (Year)	5 years
Machinery and Equipment [Member] | Maximum [Member]
Estimated useful lives (Year)	15 years

Note 7 - Intangible Assets an_3

Note 7 - Intangible Assets and Goodwill (Details Textual) - USD ($) $ in Thousands	Apr. 04, 2019	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets, Remaining Amortization Period (Year)			11 years 8 months 12 days
Goodwill, Impairment Loss		$ 3,900	$ 3,915	$ 0
Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life (Year)			15 years
Customer Relationships [Member] | MGI Grain Processing, LLC [Member]
Finite-Lived Intangible Asset, Useful Life (Year)	15 years

Note 7 - Intangible Assets an_4

Note 7 - Intangible Assets and Goodwill - Intangible Assets, Excluding Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Intangible assets, gross	$ 965	$ 997
Intangible assets, accumulated amortization	438	275
Intangible assets, net	$ 527	722
Customer Relationships [Member]
Intangible assets, useful life (Year)	15 years
Intangible assets, gross	$ 930	930
Intangible assets, accumulated amortization	423	236
Intangible assets, net	$ 507	694
Trademarks [Member]
Intangible assets, useful life (Year)	10 years
Intangible assets, gross	$ 13	13
Intangible assets, accumulated amortization	3	2
Intangible assets, net	$ 10	11
Noncompete Agreements [Member]
Intangible assets, useful life (Year)	5 years
Intangible assets, gross	$ 22	22
Intangible assets, accumulated amortization	12	8
Intangible assets, net	$ 10	14
Other Intangible Assets [Member]
Intangible assets, useful life (Year)	17 years
Intangible assets, gross	$ 0	32
Intangible assets, accumulated amortization	0	29
Intangible assets, net	$ 0	$ 3

Note 7 - Intangible Assets an_5

Note 7 - Intangible Assets and Goodwill - Future Intangible Amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
2022	$ 147
2023	111
2024	80
2025	58
2026	42
Thereafter	89
Total amortization	$ 527	$ 722

Note 7 - Intangible Assets an_6

Note 7 - Intangible Assets and Goodwill - Summary of Goodwill Activity (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Goodwill, January 1		$ 3,915	$ 3,915
Impairment of goodwill	$ (3,900)	(3,915)	0
Goodwill, December 31	$ 0	$ 0	$ 3,915

Note 8 - Leases (Details Textua

Note 8 - Leases (Details Textual) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Finance Lease, Right-of-Use Asset, before Accumulated Amortization	$ 0.5
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	0.1	$ 0.1
Property and Equipment [Member]
Finance Lease, Right-of-Use Asset, after Accumulated Amortization, Total	$ 0.2

Note 8 - Leases - Components of

Note 8 - Leases - Components of Lease Expense and Cash Flows from Leases (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Amortization of right-of use assets, included in cost of goods sold	$ 89	$ 62
Interest on lease liabilities	11	14
Fixed leases cost	515	517
Variable lease cost	149	127
Short-term lease cost	61	9
Total lease cost	825	729
Operating cash flows from finance leases	11	14
Operating cash flows from operating leases	515	517
Financing cash flows from finance leases	$ 96	$ 101

Note 8 - Leases - Remaining Ter

Note 8 - Leases - Remaining Terms and Discount Rates (Details)	Dec. 31, 2021
Weighted average remaining lease terms (in years), operating leases (Year)	6 years 2 months 12 days
Weighted average remaining lease terms (in years), finance leases (Year)	2 years 7 months 6 days
Weighted average discount rate, operating leases	7.70%
Weighted average discount rate, finance leases	4.90%
Minimum [Member]
Remaining leases terms (in years), operating leases (Year)	1 year 9 months 18 days
Remaining leases terms (in years), finance leases (Year)	4 months 24 days
Discount rates, operating leases	6.30%
Discount rates, finance leases	2.80%
Maximum [Member]
Remaining leases terms (in years), operating leases (Year)	11 years 2 months 12 days
Remaining leases terms (in years), finance leases (Year)	4 years 9 months 18 days
Discount rates, operating leases	9.00%
Discount rates, finance leases	7.30%

Note 8 - Leases - Maturities of

Note 8 - Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Dec. 31, 2021USD ($)
2022, operating leases	$ 548
2022, finance leases	93
2023, operating leases	528
2023, finance leases	63
2024, operating leases	429
2024, finance leases	23
2025, operating leases	439
2025, finance leases	9
2026, operating leases	451
2026, finance leases	7
Thereafter, operating leases	578
Thereafter, finance leases	0
Total lease payments, operating leases	2,973
Total lease payments, finance leases	195
Amounts representing interest, operating leases	(643)
Amounts representing interest, finance leases	(9)
Present value of lease obligations, operating leases	2,330
Present value of lease obligations, finance leases	$ 186

Note 9 - Debt (Details Textual)

Note 9 - Debt (Details Textual) - USD ($) $ in Thousands	10 Months Ended	12 Months Ended
	Oct. 31, 2019	Dec. 31, 2021	Dec. 31, 2020	Apr. 30, 2020
Long-term Debt, Total		$ 2,539	$ 3,679
Long-term Debt, Gross		2,571
Gain (Loss) on Extinguishment of Debt, Total		$ 1,792	$ 0
Factoring Agreement [Member] | Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 7,000
Debt Instrument, Term (Year)	2 years
Debt Instrument, Fee Amount	$ 200
Line of Credit Facility, Funding Fee, Percentage Above Prime Rate	0.50%
Line of Credit Facility, Funding Fee, Minimum Percentage	5.50%
Mortgage Agreement [Member]
Debt Instrument, Interest Rate, Stated Percentage		10.30%	10.30%
Long-term Debt, Total		$ 2,469	$ 1,817
Proceeds from Issuance of Long-term Debt, Total		1,200
Long-term Debt, Gross		1,300
Gain (Loss) on Extinguishment of Debt, Total		$ 0
Debt Instrument, Basis Spread on Variable Rate		7.00%	7.00%
Debt Instrument, Facility Fee, Percentage of Each Advance			1.00%
Old Note Prior to Modification [Member]
Long-term Debt, Gross		$ 1,300
Mortgage Agreement, at Modification [Member]
Long-term Debt, Gross		$ 1,200
Original Mortgage Agreement [Member]
Debt Instrument, Interest Rate, Stated Percentage		14.30%
Debt Instrument, Periodic Payment, Total		$ 1,000
Original Mortgage Agreement [Member] | Prime Rate [Member]
Debt Instrument, Basis Spread on Variable Rate		11.00%
Paycheck Protection Program CARES Act [Member]
Debt Instrument, Interest Rate, Stated Percentage		1.00%	1.00%
Long-term Debt, Total		$ 0	$ 1,792	$ 1,800
Finance Agreements for Annual Insurance Premiums [Member]
Debt Instrument, Interest Rate, Stated Percentage		3.70%

Note 9 - Debt - Due Under Facto

Note 9 - Debt - Due Under Factoring Agreement (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Debt issuance costs	$ (32)
Due under factoring agreement	3,379	$ 1,785
Factoring Agreement [Member] | Line of Credit [Member]
Original principal	3,379	1,860
Debt issuance costs	0	(75)
Due under factoring agreement	3,379	1,785
Average borrowings outstanding (in thousands)	1,622	1,713
Amortization of debt issuance costs (in thousands)	$ 75	$ 91
Fees paid, as a percentage of average oustanding borrowings	6.20%	7.30%
Interest paid, as a percentage of average outstanding borrowings	6.40%	6.40%

Note 9 - Debt - Long-term Debt

Note 9 - Debt - Long-term Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Apr. 30, 2020
Total long term debt, net	$ 2,539	$ 3,679
Total long term debt, net	2,539	3,679
Mortgage Agreement [Member]
Total long term debt, net	2,469	1,817
Total long term debt, net	2,469	1,817
Paycheck Protection Program CARES Act [Member]
Total long term debt, net	0	1,792	$ 1,800
Total long term debt, net	0	1,792	$ 1,800
Equipment Notes, May 2021 [Member] | Notes Payable, Other Payables [Member]
Total long term debt, net	33	0
Total long term debt, net	33	0
Equipment Notes, December 2019 [Member] | Notes Payable, Other Payables [Member]
Total long term debt, net	26	33
Total long term debt, net	26	33
Equipment Notes, November 2018 [Member] | Notes Payable, Other Payables [Member]
Total long term debt, net	11	37
Total long term debt, net	$ 11	$ 37

Note 9 - Debt - Long-term Deb_2

Note 9 - Debt - Long-term Debt (Details) (Parentheticals) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Issuance costs	$ 32,000
Mortgage Agreement [Member]
Interest rate	10.30%	10.30%
Interest rate, variable	7.00%	7.00%
Issuance costs	$ 32,000	$ 32,000
Original principal	2,500,000	2,500,000
Original principal	$ 2,500,000	$ 2,500,000
Paycheck Protection Program CARES Act [Member]
Interest rate	1.00%	1.00%
Equipment Notes, May 2021 [Member] | Notes Payable, Other Payables [Member]
Interest rate	3.60%
Original principal	$ 46,000
Original principal	$ 46,000
Equipment Notes, December 2019 [Member] | Notes Payable, Other Payables [Member]
Interest rate	9.30%	9.30%
Original principal	$ 40	$ 40
Original principal	$ 40	$ 40
Equipment Notes, November 2018 [Member] | Notes Payable, Other Payables [Member]
Interest rate	4.80%	4.80%

Note 9 - Debt - Future Principa

Note 9 - Debt - Future Principal Maturities of Long-term Debt Outstanding (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
2022	$ 1,215
2023	1,332
2024	19
2025	5
Principal maturities	2,571
Debt issuance costs	(32)
Total long term debt, net	$ 2,539	$ 3,679

Note 10 - Equity, Share-based_3

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings (Details Textual) - USD ($) $ / shares in Units, $ in Millions		Sep. 13, 2021	Feb. 28, 2022	Mar. 17, 2022	Sep. 30, 2021	Dec. 31, 2021		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019	Jun. 30, 2020	Jun. 30, 2018
Common Stock, Shares Authorized (in shares)						150,000,000		150,000,000		150,000,000			50,000,000
Proceeds from Issuance or Sale of Equity, Total						$ 3.6
Common Stock, Capital Shares Reserved for Future Issuance (in shares)						5,813,021		5,813,021
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance (in shares)						8,750,673	[1]	8,750,673	[1]	6,645,916	[1]	7,532,280
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)								1 year 8 months 12 days
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount						$ 0.2		$ 0.2
Share-based Compensation Arrangement by Share-based Payment Award, NonOption Equity Instruments, Weighted Average Exercise Price (in dollars per share)						$ 0.96		$ 0.96		$ 0.96	[2]
Share-based Payment Arrangement, Option [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award Options Exercisable Period (Year)										3 years
Share-based Payment Arrangement, Option [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award Options Exercisable Period (Year)										4 years
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance (in shares)						1,409,303		1,409,303		386,403
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)								$ 0.55
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)										2 years
Share-based Compensation Arrangement by Share-based Payment Award, Non Option Equity Instruments Impact of Warrant Modification, Prior To Modification (in shares)	[3]							0		227,062
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)						1,266,033		1,266,033		1,495,400		1,148,062
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Impact Of Warrant Modification After Modification (in shares)	[4]							0		620,000
Share-based Compensation Arrangement by Share-based Payment Award, Nonoption, Equity Instruments Impact Of Warrant Modification After Modification Vesting, Percentage										50.00%
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)	[5]							1,051,149		386,403
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)	[6]							824,689		1,261,803
Restricted Stock Units (RSUs) [Member] | Subsequent Event [Member] | Share-based Payment Arrangement, Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)				$ 0.91
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)				224,751
Restricted Stock Units (RSUs) [Member] | Share-based Payment Arrangement, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)												5 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year)								2 years		2 years
Number of Trading Days (Day)										65 days		65 days
Share-based Compensation Arrangement by Share-based Payment Award, Award VestingP rice (in dollars per share)										$ 10
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)										68,119
Restricted Stock Units (RSUs) [Member] | Share-based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non Option Equity Instruments Impact of Warrant Modification, Prior To Modification (in shares)										22,706
Share-based Compensation Arrangement by Share-based Payment Award, Award VestingP rice (in dollars per share)										$ 5
Restricted Stock Units (RSUs) [Member] | Share-based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award VestingP rice (in dollars per share)										$ 15
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)										136,237
Deferred Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance (in shares)						1,209,092		1,209,092
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (in shares)								865,052
Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)						8,750,673		8,750,673
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)						$ 1		$ 1
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance (in shares)						3,484,675		3,484,675
Stock Issued During Period, Cashless Exercise Of Warrants Shares (in shares)								2,307,498		54,629
The 2014 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares)														6,300,000
Common Stock, Capital Shares Reserved for Future Issuance (in shares)						486,979		486,979
The 2014 Equity Incentive Plan [Member] | Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)								10 years
The 2014 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance (in shares)						1,000,000		1,000,000
The 2014 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Subsequent Event [Member] | Share-based Payment Arrangement, Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares)				370,000
Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number (in shares)				2
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized (in shares)				1,898,781
The Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		2,307,693				2,307,696		2,307,696
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 1				$ 1		$ 1
Class of Warrant or Right, Change in Exercise Price, Maximum Percentage of Five-day Volume Weighted Average Common Stock		110.00%						110.00%
Warrants and Rights Outstanding		$ 0.6
Share-based Compensation Arrangement by Share-based Payment Award, NonOption Equity Instruments, Weighted Average Exercise Price (in dollars per share)						$ 0.96		$ 0.96
Class of Warrant or Right, Warrants Expired During Period (in shares)			6,142,980
Class of Warrant or Right, Expired, Exercise Price (in dollars per share)			$ 0.96
Prefunded Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		2,307,855
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 0.0001
Class of Warrant or Right, Exercise Price, Prefunded (in dollars per share)		$ 0.6499
Offering Pursuant to Shelf Registration Statement [Member]
Stock Issued During Period, Shares, New Issues (in shares)		2,307,500
Proceeds from Issuance or Sale of Equity, Total		$ 2.8
Payments of Stock Issuance Costs		$ 0.2
At-the-market Offering Program [Member]
Stock Issued During Period, Shares, New Issues (in shares)					754,895					4,850,489
Proceeds from Issuance or Sale of Equity, Total						$ 0.6
Payments of Stock Issuance Costs					$ 0.1					$ 0.2
Shares Issued, Price Per Share (in dollars per share)					$ 0.80					$ 0.53
Proceeds from Issuance of Common Stock					$ 0.5
Series A Through F Preferred Stock [Member]
Preferred Stock, Shares Outstanding, Ending Balance (in shares)						0		0
Series G Preferred Stock [Member]
Preferred Stock, Shares Outstanding, Ending Balance (in shares)						150		150		225
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)						948.9915		948.9915
Preferred Stock, Liquidation Preference Per Share (in dollars per share)						$ 1,000		$ 1,000
[1]	Under the terms of certain outstanding warrants, the holders may elect to exercise the warrants under a cashless exercise feature. As of December 31, 2021, warrant holders may elect to exercise cashless warrants for 3,484,675 shares of common stock at an exercise price of $0.96 per share and 2,307,696 shares of common stock at an exercise price of $1.00 per share. If we register for resale the shares subject to warrants, the holders of some of the warrants may no longer have the right to elect a cashless exercise. If we fail to maintain a registration statement for the resale of shares under certain other warrants, the shares under those warrants may again become exercisable using a cashless exercise feature.
[2]	We issued 54,629 shares of common stock upon the cashless exercise of the warrants in 2020.
[3]	In December 2020, we modified RSUs for a total of 227,062 shares of common stock. Prior to modification, the shares subject to the RSUs vested based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days. Subject to a minimum service period, as described in the next sentence, the RSU shares vested as to (i) 22,706 shares on the date the vesting price equals or exceeds $5.00 per share, (ii) 68,119 shares on the date the vesting price equals or exceeds $10.00 per share and (iii) 136,237 shares on the date the vesting price equals or exceeds $15.00 per share. Vesting on the RSU shares would have occurred the later of the one-year anniversary of the grant and the date the shares reach the vesting price indicated in the preceding sentence. The RSUs expire on the fifth anniversary of each grant at dates ranging from October 2023 to August 2024.
[4]	In December 2020, after modification, shares subject to the modified RSUs referred to above totaled 620,000 and vest as to 50% of the shares in December 2021 and as to the remainder of the shares in December 2022. We are recognizing the total of (i) the remaining unrecognized compensation on the awards as of the modification date and (ii) the increase in fair value of the RSUs as a result of the modification, over the remaining two-year vesting period of the RSUs.
[5]	Represents the following. 2021 2020 Vested when granted 386,403 386,403 Vested upon completion of service conditions, common stock issued at vesting 572,500 - Vested upon completion of service, common stock issuance deferred 450,400 - Outstanding at December 31 1,409,303 386,403
[6]	The shares of common stock subject to the RSUs granted in 2021 and 2020, were vested when granted or vest within two years of grant. These RSU grants were not subject to any market conditions and were valued using the market price of our common stock on the date of grant. Prior to being modified in 2020, the shares of common stock subject to the RSUs granted in 2019 vested based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days, subject to a minimum service period in certain grants, and expired on the fifth anniversary of each grant.

Note 10 - Equity, Share-based_4

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Share-based Compensation Expenses Related to Employees and Directors (Details) - The 2014 Equity Incentive Plan [Member] - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Common stock	$ 1,114	$ 1,041
Common Stock, Vested at Issuance and Nonvested at Issuance [Member]
Common stock	108	308
Share-based Payment Arrangement, Option [Member]
Common stock	140	148
Restricted Stock Units (RSUs) [Member]
Common stock	$ 866	$ 585

Note 10 - Equity, Share-based_5

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Information Regarding Common Stock Issued (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Shares issued (in shares)	708,584	214,234
Weighted Average Grant Date Fair Value Per Share (in dollars per share)
Director [Member] | Common Stock [Member]
Shares issued (in shares)	136,084	83,306
Weighted Average Grant Date Fair Value Per Share (in dollars per share)	$ 0.80	$ 0.53
Employees [Member] | Common Stock [Member]
Shares issued (in shares)	572,500	71,011
Weighted Average Grant Date Fair Value Per Share (in dollars per share)	$ 0.55	$ 0.85
Consultants [Member] | Common Stock [Member]
Shares issued (in shares)	0	59,917
Weighted Average Grant Date Fair Value Per Share (in dollars per share)		$ 0.71

Note 10 - Equity, Share-based_6

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Stock Option Activity (Details) - $ / shares		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Outstanding, shares under options (in shares)		675,026	996,009
Outstanding, weighted average exercise price (in dollars per share)		$ 2.24	$ 3.23
Outstanding, weighted average remaining contractual life (Year)		6 years 10 months 24 days	7 years 10 months 24 days	8 years 1 month 6 days
Granted (1), shares under options (in shares)	[1]	0	653,004
Granted, weighted average exercise price (in dollars per share)	[1]	$ 0	$ 1.22
Granted, weighted average grant date fair value (in dollars per share)	[1]		$ 0.73
Granted, weighted average remaining contractual life (Year)	[1]		10 years
Forfeited, shares under options (in shares)		(31,067)	(973,987)
Forfeited, weighted average exercise price (in dollars per share)		$ 8.40	$ 2.56
Forfeited, weighted average remaining contractual life (Year)		7 years 4 months 24 days	8 years 1 month 6 days
Outstanding, shares under options (in shares)		643,959	675,026	996,009
Outstanding, weighted average exercise price (in dollars per share)		$ 1.95	$ 2.24	$ 3.23
[1]	The options granted vest and become exercisable in annual or monthly installments ending three or four years from the date of grant.

Note 10 - Equity, Share-based_7

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offering - Information Related to Outstanding and Exercisable (Details)	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Shares underlying options, outstanding (in shares) | shares	643,959
Weighted average exercise price, outstanding (in dollars per share)	$ 1.95
Weighted average remaining contractual life, exercisable (Year)	6 years 10 months 24 days
Shares underlying options, exercisable (in shares) | shares	352,439
Weighted average exercise price, exercisable (in dollars per share)	$ 2.18
Weighted average remaining contractual life, exercisable (Year)	6 years 2 months 12 days
Exercise Price Range One [Member]
Exercise price range, upper range limit (in dollars per share)	$ 1
Shares underlying options, outstanding (in shares) | shares	78,000
Weighted average exercise price, outstanding (in dollars per share)	$ 0.85
Weighted average remaining contractual life, exercisable (Year)	5 years 3 months 18 days
Shares underlying options, exercisable (in shares) | shares	78,000
Weighted average exercise price, exercisable (in dollars per share)	$ 0.85
Weighted average remaining contractual life, exercisable (Year)	5 years 3 months 18 days
Exercise Price Range Two [Member]
Exercise price range, upper range limit (in dollars per share)	$ 1.99
Shares underlying options, outstanding (in shares) | shares	333,811
Weighted average exercise price, outstanding (in dollars per share)	$ 1.26
Weighted average remaining contractual life, exercisable (Year)	7 years 8 months 12 days
Shares underlying options, exercisable (in shares) | shares	115,983
Weighted average exercise price, exercisable (in dollars per share)	$ 1.32
Weighted average remaining contractual life, exercisable (Year)	7 years 2 months 12 days
Exercise price range, lower range limit (in dollars per share)	$ 1
Exercise Price Range Three [Member]
Exercise price range, upper range limit (in dollars per share)	$ 2.99
Shares underlying options, outstanding (in shares) | shares	116,750
Weighted average exercise price, outstanding (in dollars per share)	$ 2.79
Weighted average remaining contractual life, exercisable (Year)	7 years 3 months 18 days
Shares underlying options, exercisable (in shares) | shares	72,687
Weighted average exercise price, exercisable (in dollars per share)	$ 2.82
Weighted average remaining contractual life, exercisable (Year)	7 years 1 month 6 days
Exercise price range, lower range limit (in dollars per share)	$ 2
Exercise Price Range Four [Member]
Exercise price range, upper range limit (in dollars per share)	$ 3.99
Shares underlying options, outstanding (in shares) | shares	89,875
Weighted average exercise price, outstanding (in dollars per share)	$ 3.34
Weighted average remaining contractual life, exercisable (Year)	6 years 3 months 18 days
Shares underlying options, exercisable (in shares) | shares	60,256
Weighted average exercise price, exercisable (in dollars per share)	$ 3.36
Weighted average remaining contractual life, exercisable (Year)	5 years 10 months 24 days
Exercise price range, lower range limit (in dollars per share)	$ 3
Exercise Price Range Five [Member]
Exercise price range, upper range limit (in dollars per share)	$ 4.99
Shares underlying options, outstanding (in shares) | shares	23,104
Weighted average exercise price, outstanding (in dollars per share)	$ 4.43
Weighted average remaining contractual life, exercisable (Year)	2 years 7 months 6 days
Shares underlying options, exercisable (in shares) | shares	23,094
Weighted average exercise price, exercisable (in dollars per share)	$ 4.43
Weighted average remaining contractual life, exercisable (Year)	2 years 7 months 6 days
Exercise price range, lower range limit (in dollars per share)	$ 4
Exercise Price Range Six [Member]
Exercise price range, upper range limit (in dollars per share)	$ 74
Shares underlying options, outstanding (in shares) | shares	2,419
Weighted average exercise price, outstanding (in dollars per share)	$ 16
Weighted average remaining contractual life, exercisable (Year)	9 months 18 days
Shares underlying options, exercisable (in shares) | shares	2,419
Weighted average exercise price, exercisable (in dollars per share)	$ 16
Weighted average remaining contractual life, exercisable (Year)	9 months 18 days
Exercise price range, lower range limit (in dollars per share)	$ 5

Note 10 - Equity, Share-based_8

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Assumptions Used in Valuing Stock Option Grants (Details)	12 Months Ended
	Dec. 31, 2020
Assumed volatility, minimum	60.00%
Assumed volatility, maximum	69.00%
Assumed volatility, weighted average	62.00%
Assumed risk free interest rate, minimum	1.30%
Assumed risk free interest rate, maximum	1.70%
Weighted Average [Member]
Assumed risk free interest rate	1.60%
Average expected life of options (in years) (Year)	6 years 3 months 18 days
Minimum [Member]
Average expected life of options (in years) (Year)	5 years 10 months 24 days
Maximum [Member]
Average expected life of options (in years) (Year)	7 years

Note 10 - Equity, Share-based_9

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Restricted Stock Unit Activity (Details) - USD ($)		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Weighted average remaining contractual life (Year)		1 year 4 months 24 days	[1]	1 year 1 month 6 days	[1]	1 year 10 months 24 days
Restricted Stock Units (RSUs) [Member]
Nonvested, shares issued (in shares)		1,495,400		1,148,062
Nonvested, unrecognized stock compensation		$ 730		$ 377
Weighted average remaining contractual life (Year)		10 months 24 days		1 year 4 months 24 days
Granted, nonvested, shares issued (in shares)	[2]	824,689		1,261,803
Granted, unrecognized stock compensation	[2]	$ 796		$ 828
Granted, weighted average expense period (Year)	[2]	1 year		10 months 24 days
Before modification, shares issued (in shares)	[3]	0		(227,062)
Before modification, unrecognized stock compensation	[3]	$ 0		$ (22)
After modification, shares issued (in shares)	[4]	0		620,000
After modification, unrecognized stock compensation	[4]	$ 0		$ 353
After modification, weighted average expense period (Year)	[4]			2 years
Vested, shares issued (in shares)	[5]	(1,051,149)		(386,403)
Cancelled, shares issued (in shares)		0		(625,000)
Forfeited, shares issued (in shares)	[6]	(2,907)		(296,000)
Forfeited, unrecognized stock compensation	[6]	$ (3)		$ (221)
Expensed, unrecognized stock compensation		$ (865)		$ (585)
Nonvested, shares issued (in shares)		1,266,033		1,495,400		1,148,062
Nonvested, unrecognized stock compensation		$ 658		$ 730		$ 377
[1]	We issued 54,629 shares of common stock upon the cashless exercise of the warrants in 2020.
[2]	The shares of common stock subject to the RSUs granted in 2021 and 2020, were vested when granted or vest within two years of grant. These RSU grants were not subject to any market conditions and were valued using the market price of our common stock on the date of grant. Prior to being modified in 2020, the shares of common stock subject to the RSUs granted in 2019 vested based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days, subject to a minimum service period in certain grants, and expired on the fifth anniversary of each grant.
[3]	In December 2020, we modified RSUs for a total of 227,062 shares of common stock. Prior to modification, the shares subject to the RSUs vested based upon a vesting price equal to the volume weighted average trading price of our common stock over sixty-five consecutive trading days. Subject to a minimum service period, as described in the next sentence, the RSU shares vested as to (i) 22,706 shares on the date the vesting price equals or exceeds $5.00 per share, (ii) 68,119 shares on the date the vesting price equals or exceeds $10.00 per share and (iii) 136,237 shares on the date the vesting price equals or exceeds $15.00 per share. Vesting on the RSU shares would have occurred the later of the one-year anniversary of the grant and the date the shares reach the vesting price indicated in the preceding sentence. The RSUs expire on the fifth anniversary of each grant at dates ranging from October 2023 to August 2024.
[4]	In December 2020, after modification, shares subject to the modified RSUs referred to above totaled 620,000 and vest as to 50% of the shares in December 2021 and as to the remainder of the shares in December 2022. We are recognizing the total of (i) the remaining unrecognized compensation on the awards as of the modification date and (ii) the increase in fair value of the RSUs as a result of the modification, over the remaining two-year vesting period of the RSUs.
[5]	Represents the following. 2021 2020 Vested when granted 386,403 386,403 Vested upon completion of service conditions, common stock issued at vesting 572,500 - Vested upon completion of service, common stock issuance deferred 450,400 - Outstanding at December 31 1,409,303 386,403
[6]	In 2021 and 2020, we reversed expense recognized in prior periods on forfeited RSU shares in the amounts indicated in the unrecognized stock compensation column.

Note 10 - Equity, Share-base_10

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Summary of Nonvested Common Stock Activity (Details) - shares		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Outstanding, shares (in shares)		8,750,673	[1]	6,645,916	[1]	7,532,280
Restricted Stock Units (RSUs) [Member]
Vested, shares (in shares)	[2]	1,051,149		386,403
Outstanding, shares (in shares)		1,409,303		386,403
Vested When Granted [Member] | Restricted Stock Units (RSUs) [Member]
Vested, shares (in shares)		386,403		386,403
Vested upon Completion of Service Conditions, Common Stock Issued at Vesting [Member] | Restricted Stock Units (RSUs) [Member]
Vested, shares (in shares)		572,500		0
Vested upon Completion of Service, Common Stock Issuance Deferred [Member] | Restricted Stock Units (RSUs) [Member]
Vested, shares (in shares)		450,400		0
[1]	Under the terms of certain outstanding warrants, the holders may elect to exercise the warrants under a cashless exercise feature. As of December 31, 2021, warrant holders may elect to exercise cashless warrants for 3,484,675 shares of common stock at an exercise price of $0.96 per share and 2,307,696 shares of common stock at an exercise price of $1.00 per share. If we register for resale the shares subject to warrants, the holders of some of the warrants may no longer have the right to elect a cashless exercise. If we fail to maintain a registration statement for the resale of shares under certain other warrants, the shares under those warrants may again become exercisable using a cashless exercise feature.
[2]	Represents the following. 2021 2020 Vested when granted 386,403 386,403 Vested upon completion of service conditions, common stock issued at vesting 572,500 - Vested upon completion of service, common stock issuance deferred 450,400 - Outstanding at December 31 1,409,303 386,403

Note 10 - Equity, Share-base_11

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Warrants Activity (Details) - $ / shares		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Outstanding, balance (in shares)		6,645,916	[1]	7,532,280
Outstanding, weighted average exercise price (in dollars per share)		$ 0.98	[2]	$ 1.32
Weighted average remaining contractual life (Year)		1 year 4 months 24 days	[2]	1 year 1 month 6 days	[2]	1 year 10 months 24 days
Granted (1) (in shares)	[3]	2,307,693
Granted, weighted average exercise price (in dollars per share)	[3]	$ 1
Granted, weighted average remaining contractual life (Year)	[3]	5 years
Cash exercised (in shares)		(177,936)		(12,948)
Share-based Compensation Arrangement by Share-based Payment Award, NonOption Equity Instruments, Weighted Average Exercise Price (in dollars per share)		$ 0.96		$ 0.96	[2]
Cash exercised, weighted average remaining contractual life (Year)		9 months 18 days
Cashless exercised (2) (in shares)	[2]			(215,740)
Cashless exercised, weighted average exercise price (in dollars per share)		$ 0.96		$ 0.96	[2]
Expired (in shares)		(25,000)		(657,676)
Expired, weighted average exercise price (in dollars per share)		$ 5.25		$ 5.25
Outstanding, balance (in shares)		8,750,673	[1]	6,645,916	[1]	7,532,280
Outstanding, weighted average exercise price (in dollars per share)		$ 0.98	[2]	$ 0.98	[2]	$ 1.32
[1]	Under the terms of certain outstanding warrants, the holders may elect to exercise the warrants under a cashless exercise feature. As of December 31, 2021, warrant holders may elect to exercise cashless warrants for 3,484,675 shares of common stock at an exercise price of $0.96 per share and 2,307,696 shares of common stock at an exercise price of $1.00 per share. If we register for resale the shares subject to warrants, the holders of some of the warrants may no longer have the right to elect a cashless exercise. If we fail to maintain a registration statement for the resale of shares under certain other warrants, the shares under those warrants may again become exercisable using a cashless exercise feature.
[2]	We issued 54,629 shares of common stock upon the cashless exercise of the warrants in 2020.
[3]	Represents Warrant A and is classified as a liability in our consolidated balance sheets. The $1.00 per share exercise price as of December 31, 2021, is subject to adjustment in September 2022, and again in September 2023, if 110% of the 5-day volume weighted average price of our common stock is less than the then-current exercise price.

Note 10 - Equity, Share-base_12

Note 10 - Equity, Share-based Compensation, Warrants and Securities Offerings - Exercisable and Outstanding (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021		Dec. 31, 2020	[1]	Dec. 31, 2019
Weighted Average Exercise Price (in dollars per share)	$ 0.98	[1]	$ 0.98		$ 1.32
Weighted average remaining contractual life (Year)	1 year 4 months 24 days	[1]	1 year 1 month 6 days		1 year 10 months 24 days
Warrants [Member]
Shares under warrants (in shares)	8,750,673
Weighted Average Exercise Price (in dollars per share)	$ 0.98
Weighted average remaining contractual life (Year)	1 year 4 months 24 days
Exercise Range One [Member] | Warrants [Member]
Shares under warrants (in shares)	6,392,980
Weighted Average Exercise Price (in dollars per share)	$ 0.96
Weighted average remaining contractual life (Year)	1 month 6 days
Exercise Price Range Two [Member] | Warrants [Member]
Shares under warrants (in shares)	2,307,693
Weighted Average Exercise Price (in dollars per share)	$ 1
Weighted average remaining contractual life (Year)	4 years 8 months 12 days
Exercise Price Range Three [Member] | Warrants [Member]
Shares under warrants (in shares)	50,000
Weighted Average Exercise Price (in dollars per share)	$ 2
Weighted average remaining contractual life (Year)	1 year 1 month 6 days
[1]	We issued 54,629 shares of common stock upon the cashless exercise of the warrants in 2020.

Note 11 - Income Taxes (Details

Note 11 - Income Taxes (Details Textual) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Domestic Tax Authority [Member]
Operating Loss Carryforwards, Total	$ 50.1
Operating Loss Carryforwards, Subject To Expiration		$ 9.9
Domestic Tax Authority [Member] | Minimum [Member]
Operating Loss Carryforwards, Expiration Date	Dec. 31, 2022
Domestic Tax Authority [Member] | Maximum [Member]
Operating Loss Carryforwards, Expiration Date	Dec. 31, 2037
State and Local Jurisdiction [Member]
Operating Loss Carryforwards, Subject To Expiration	$ 59.5
State and Local Jurisdiction [Member] | Minimum [Member]
Operating Loss Carryforwards, Expiration Date	Jan. 1, 2022
State and Local Jurisdiction [Member] | Maximum [Member]
Operating Loss Carryforwards, Expiration Date	Dec. 31, 2041

Note 11 - Income Taxes - Deferr

Note 11 - Income Taxes - Deferred Tax Asset (Liability) (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net operating loss carryforwards	$ 13,385	$ 11,473
Stock options and warrants	832	576
Property and equipment	16	50
Intangible assets	950	(9)
Capitalized expenses	105	85
Other	64	135
Operating right-of-use lease assets	(566)	(652)
Operating right-of-use lease liabilities	670	763
Net deferred tax assets	15,456	12,421
Less: Valuation allowance	(15,456)	(12,421)	$ (8,687)
Deferred tax asset (liability)	$ 0	$ 0

Note 11 - Income Taxes - Summar

Note 11 - Income Taxes - Summarizes the Changes in the Valuation Allowance (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Vaulation allowances, beginning of year	$ 12,421	$ 8,687
Net operating loss and other temporary differences	2,926	3,039
Expiration of net operating losses and limitations	0	(20)
Adjustment to deferred taxes	67	(51)
Impact of state tax rate change	42	746
Other adjusments	0	20
Valuation allowance, end of year	$ 15,456	$ 12,421

Note 11 - Income Taxes - Income

Note 11 - Income Taxes - Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income tax benefit at federal statutory rate	$ (1,875)	$ (2,459)
State tax benefit, net of federal tax effect	(605)	(623)
Effect of change in state tax rate	(42)	(746)
Change in valuation allowance	3,035	3,734
Expirations of net operating losses and application of IRC 382 limitation	0	20
PPP loan forgiveness, nontaxable	(376)	0
Change in fair value of derivative warrant liability, nontaxable	(81)	0
Other nondeductible expenses	32	0
Adjustments to deferreds	(67)	51
Other	0	42
Income tax expense	$ 21	$ 19

Note 12 - Income (Loss) Per S_3

Note 12 - Income (Loss) Per Share (EPS) -EPS Compensations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Basic and diluted - net loss	$ (8,949)	$ (11,730)
Weighted average number of shares of shares of common stock outstanding (in shares)	47,105,673	41,019,802
Weighted average number of shares of common stock underlying vested restricted stock units (in shares)	633,275	111,980
Basic EPS - weighted average number of shares outstanding (in shares)	47,738,948	41,131,782
Diluted EPS - weighted average number of shares outstanding (in shares)	47,738,948	41,131,782

Note 13 - Fair Value Measurem_3

Note 13 - Fair Value Measurement (Details Textual) - Fair Value, Recurring [Member] - Fair Value, Inputs, Level 3 [Member] $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)$ / shares
Operating Lease, Fair Value In Excess Of Carrying Amount	$ 200
Measurement Input, Exercise Price [Member]
Warrants and Rights Outstanding, Measurement Input	1
Warrant, Exercise Price, Increase (in dollars per share) | $ / shares	$ 0.10
Fair Value Adjustment of Warrants	$ 130

Note 13 - Fair Value Measurem_4

Note 13 - Fair Value Measurement - Fair Value of Liabilities on Recurring Basis (Details) - Fair Value, Recurring [Member] $ in Thousands	Dec. 31, 2021USD ($)
Derivative warrant liability	$ 258
Total liabilities at fair value	258
Fair Value, Inputs, Level 1 [Member]
Derivative warrant liability	0
Total liabilities at fair value	0
Fair Value, Inputs, Level 2 [Member]
Derivative warrant liability	0
Total liabilities at fair value	0
Fair Value, Inputs, Level 3 [Member]
Derivative warrant liability	258
Total liabilities at fair value	$ 258

Note 13 - Fair Value Measurem_5

Note 13 - Fair Value Measurement - Changes in Level 3 Items Measured at Fair Value (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)
Fair value as of beginning of period	$ 0
Total realized and unrealized gains (losses)	0
Issuance of new instruments	647
Net transfers (into) out of level 3	0
Fair value at end of period	258
Change in unrealized gains (losses) on instruments still held	$ (389)

Note 13 - Fair Value Measurem_6

Note 13 - Fair Value Measurement - Fair Value Assumption Measurement of Warrant A (Details)	Dec. 31, 2021	Sep. 30, 2021
Measurement Input, Price Volatility [Member]
Warrants and Rights Outstanding, Measurement Input	69.5	71
Measurement Input, Risk Free Interest Rate [Member]
Warrants and Rights Outstanding, Measurement Input	0.008	0.004
Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input	4.8	5

Note 14 - Commitments and Con_2

Note 14 - Commitments and Contingencies (Details Textual) $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)
Contract Dispute [Member] | Cost of Sales [Member]
Litigation Settlement, Expense	$ 0.8

Note 15 - Related Party Trans_2

Note 15 - Related Party Transactions (Details Textual) - Continental Grain Company [Member]	12 Months Ended
	Dec. 31, 2021
Related Party, Right to Designate to Board of Directors, Number of Nominees	1
RiceBran Technologies [Member]
Ownership Percentage	20.60%